H-1B sponsorship profile: United Therapeutics Corporation. Across U.S. Department of Labor LCA disclosures, United Therapeutics Corporation filed 33 Labor Condition Applications covering 33 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 97% (32 certified of 33 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on United Therapeutics Corporation’s H-1B petitions range from $69,909 at the low end to $246,607 at the high end, with a petition-weighted average of $134,901. That range reflects the mix of occupations the company sponsors, led by Senior Salesforce & Integration Developer (3 petitions at $148,484 avg), followed by Senior Validation Engineer, CSV and Senior Print Process Engineer. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. United Therapeutics Corporation is headquartered in SILVER SPRING, MD under NAICS code 325412, and places H-1B workers across 5 states, most heavily in MD, NC, NH. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where United Therapeutics Corporation ranks. By H-1B petition volume, United Therapeutics Corporation is #6,779 of 119,880 employers nationally and #114 of 2,045 employers headquartered in MD. Both ranks are computed live from the same underlying petition counts, not a separate estimate.